This After-Action Review (AAR) investigates the use of evidence in Norway’s advice-making process about school continuity in secondary (13–15 years old) and upper secondary schools (16–18 years old) during the COVID-19 pandemic.
This generic protocol for ECDC studies describes the design and methods for a prospective multi-country cohort study of hospital-based healthcare workers (HCWs) to evaluate the effectiveness of COVID-19 vaccine in preventing laboratory-confirmed SARS-CoV-2 infection.
This core protocol for ECDC studies of VE against hospitalisation with SARI laboratory-confirmed with SARS-CoV-2 or with influenza, version 3.0, represents an update to the main elements for a multi-country hospital-based study of COVID-19 vaccine effectiveness in patients hospitalised with SARI, initially published as version 1.0 [5], updated to version 2.0 [6].
This document aims to collate and present the lessons identified from the public health stakeholders who responded to the COVID-19 pandemic. It is intended to serve as input for countries revising their pandemic or emergency preparedness plans.
The workshop organised by ECDC took place from 7 - 9 March in Tunis, upon invitation of the Tunisian National Observatory of New and Emerging Diseases (NONED).
This report presents pooled COVID-19 vaccine effectiveness (VE) estimates for the first, second and third booster doses, against hospitalisation due to COVID-19 and COVID-19 related deaths in resident populations ≥50 years of age, living in the community.
A recent ECDC report, ‘Prevalence of post COVID-19 condition symptoms: A systematic review and meta-analysis of cohort study data stratified by recruitment setting’ reveals that post –COVID-19 symptoms appear to be more prevalent amongst patients from hospital settings when compared to community settings.
ECDC's COVID-19 Vaccine Tracker is an interactive dashboard which provides an overview of the progress in the roll-out of COVID-19 vaccines in adults across EU/EEA Member States.
The public health advice-making process on schools in Sweden during the COVID-19 pandemic from November 2020 to April 2021 has undergone an After-Action Review (AAR), with results now available in a new report by ECDC and the Public Health Agency of Sweden, Folkhälsomyndigheten.